U.S. and Europe Advance Binding Security Guarantees for Ukraine After Paris Talks 
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
Tabletop particle accelerator could transform medicine and materials science 
Five Years After January 6 Capitol Riot, Democrats and Republicans Clash Over History and Power 
Trump Administration Denies Nation-Building Plans After Venezuela Military Operation 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Samsung Electronics Poised for Massive Q4 Profit Surge on Soaring Memory Chip Prices 
Australia Orders Independent Review After Bondi Mass Shooting, Albanese Resists Royal Commission Calls 
China Rejects U.S. Role as “World’s Judge” After Maduro’s Arrest 
Trump Administration Freezes Federal Child Care Funds Over Fraud Concerns 
Trump Administration Expands U.S. Visa Bond Requirement to 38 Countries 
Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
